Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Optimized liposomes can improve drug delivery and effectiveness.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Acitretin effectively treats severe hypertrophic lichen planus.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Bilobetin may help reduce acne by decreasing sebum production.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

The FDA approved a new Pfizer drug for hair loss in teens.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Myoinositol effectively manages PCOS with fewer side effects than metformin.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Minoxidil solution applied twice daily improved hair growth in patients with Woolly Hair/Hypotrichosis due to LIPH gene issues, with mild side effects.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.